Secondary cytoreductive surgery and oncologic outcomes in the era of targeted maintenance therapy for recurrent, platinum-sensitive ovarian cancer

CONCLUSIONS: CGR during SCS is associated with improved PFS2 compared to suboptimal resection. Prospective randomized trials are warranted to elucidate the role of SCS as more therapeutics become available.PMID:38640773 | DOI:10.1016/j.ygyno.2024.03.006

Source: Gynecologic Oncology - April 19, 2024 Category: Cancer & Oncology Authors: Sarah Ehmann Clarissa Lam Qin Zhou Alexia Iasonos Rachel N Grisham William P Tew Roisin E O'Cearbhaill Kara Long Roche Oliver Zivanovic Yukio Sonoda Dennis S Chi Ginger J Gardner Source Type: research